Cannabis products with high levels of the psychedelic element found in marijuana — tetrahydrocannabinol, or THC — may be associated with improvements in chronic pain, according to a study published this month in the Annals of Internal Medicine.
Researchers examined ratios between THC and cannabidiol, or CBD, and found that synthetic, oral products with high THC-to-CBD ratios and sublingual, extracted cannabis products with comparable THC-to-CBD ratios “may be associated with short-term improvements in chronic pain,” according to the study.
The study, whi...
Comments